Related Experiment Video
Updated: Jul 7, 2026

Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations
Published on: January 10, 2015
Tobacco use in the European region
Kathleen Strong1, Regina Guthold, Ju Yang
1Department of Chronic Diseases and Health Promotion, World Health Organization, Geneva, Switzerland. strongk@who.int
Abstract:
This paper presents comparable tobacco use prevalence estimates for the WHO European region for two common definitions of tobacco use: current smoker (occasional and daily) and daily smoker. Data collections held in the WHO Global InfoBase (www.who.int/infobase) were used to examine patterns of tobacco use at the country level, in the region as a whole and for specific subregional groups. Data from 275 sources presenting tobacco use prevalence by age and sex and representing 46 out of 52 countries in the WHO European region met the inclusion criteria. Regression models were used to adjust country-reported prevalence to a standard set of definitions and age groups. Estimates were projected to a set of standard reporting years, 2002, 2005 and 2015. The prevalence of current smoking and daily smoking was 33.2 and 28.4%, respectively in 2002. Male smokers had overall higher prevalence of daily smoking, 37.7% and current smoking, 43.1% in 2002. The corresponding rates for female smokers were 19.3% for daily smokers and 23.4% for current smokers in 2002. The overall prevalence declines slightly by 2015 for male daily smokers to 33.5% but increases for female daily smokers to 20.1%. The increase in female smokers is most apparent in the eastern, southern and western parts of Europe.
More Related Videos
09:30A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol
Published on: January 18, 2018
09:50Impact Assessment of Repeated Exposure of Organotypic 3D Bronchial and Nasal Tissue Culture Models to Whole Cigarette Smoke
Published on: February 12, 2015
Related Concept Videos
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Statistical Methods for Analyzing Epidemiological Data
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
Stress Prevention and Stress Management Techniques IV
CNS Depressants: Alcohol and Nicotine
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features